CSX Corporation Declares $0.14 Quarterly Dividend for December Payment
CSX Corporation declared a $0.14 quarterly dividend payable in December. Here is what shareholders need to know about the payment timeline.
Market news
Every story explained in plain English, with the prices that matter beside it.
CSX Corporation Declares Quarterly Dividend of $0.14 Per Share
CSX Corporation approved a quarterly dividend of $0.14 per share, payable in December to shareholders of record as of late November.
Premiere Digital Acquires Vubiquity From Amdocs to Expand Global Distribution Scale
Premiere Digital has acquired Vubiquity from Amdocs to build a global digital distribution leader, though financial terms remain undisclosed.
MergersNeutral
NeuroOne Joins Dartmouth Research Team on 1 Million Dollar NIH Brain Sensor Grant
NeuroOne Medical Technologies will receive 200,000 dollars through a subaward to help develop next-generation brain activity monitoring tools.
NeuroOne Medical Technologies Secures NIH Subaward for Electrode Research
NeuroOne Medical Technologies received a subaward of about $200,000 to advance its electrode technology in collaboration with Dartmouth.
Bank of America Reduces Lakefront Biotherapeutics Stake Below 10 Percent
Bank of America lowered its stake in Lakefront Biotherapeutics to 8.54 percent, triggering a regulatory disclosure.
Fluid Powers Bitcoin-Backed Loans for Hashi Mainnet Launch With Over 500 Million Dollars Committed
Fluid integrates with Hashi mainnet to enable Bitcoin-backed loans, potentially driving fee growth despite a decline in the token's price.
Onyxcoin Community to Vote on Token Buybacks and Onyx Launch
Onyxcoin is launching a governance vote on proposal OIP-5 to introduce token buybacks, fee burns, and deploy the new Onyx Launch platform.
Samsung Integrates Solana to Enable Cross-Border USDC Payments on Galaxy Devices
Samsung has partnered with Solana to bring cross-border USDC stablecoin payments to 82 million Galaxy devices, expanding mobile crypto utility.
XORTX Therapeutics Outlines Plan to File Canadian Clinical Trial Application for Gout Drug XORLO
XORTX Therapeutics plans to submit a Clinical Trial Application in Canada for its gout treatment XORLO to accelerate its regulatory pathway to the FDA.
Nuveen to Rebrand Two Municipal Closed-End Funds
Two Nuveen municipal closed-end funds are changing their names on October 30, 2026, while keeping their core investment strategies intact.
Nuveen Municipal Value Funds Adopt New 80% Investment Policies
Two Nuveen closed-end municipal value funds will implement new investment policies on October 30, 2026, requiring them to hold 80% in municipal bonds.
Lattice Semiconductor Wins 2026 Award for Post-Quantum Cryptography Chips
Lattice Semiconductor wins a 2026 cybersecurity award for its quantum-resistant chips, but its stock falls nearly 5% to close at 124.5 USD.
US Spot Bitcoin ETFs See $484.9 Million in Outflows as BlackRock Leads Withdrawals
US spot Bitcoin ETFs recorded $484.9 million in net outflows on October 7, led by a sharp $207.7 million withdrawal from BlackRock's fund.
CryptoBearish
XORTX Therapeutics Plans Clinical Trial Application in Canada for Gout Drug XORLO
XORTX Therapeutics plans to file a clinical trial application in Canada for its gout treatment XORLO to accelerate its planned FDA approval pathway.
Data Center REITs See Strong Demand Amid AI Infrastructure Expansion
AI infrastructure growth drives demand for data center REITs like Equinix and Digital Realty despite high interest rates.
Tevogen Inc. Signs Letter of Intent for Potential Deal With HRK Healthcare
Tevogen Inc. has signed a letter of intent to evaluate a potential transaction with HRK Healthcare LLC, aiming for a path to $100M in annual revenue.
Tevogen Signs Letter of Intent to Evaluate HRK Healthcare Acquisition
Tevogen Inc. signs a letter of intent to evaluate acquiring HRK Healthcare LLC to expand services and target 100 million dollars in annual revenue.
US Launches Visa Fraud Probe at Top Universities and Suspends Tech Firms from Labor Program
The US government has launched a J-1 visa fraud probe at nine elite universities and suspended major IT outsourcing firms from a key labor program.
Mizuho Downgrades Phillips 66, Delek, and Par Pacific Citing Limited Upside
Mizuho downgraded Phillips 66, Delek, and Par Pacific to neutral after massive year-to-date gains, saying current stock prices fully reflect earnings growth.